14 completed, 3 unknown, 2 terminated, 1 recruiting. 22 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 22 | Completed 14, Unknown 3, Terminated 2, Recruiting 1, Suspended 1, Withdrawn 1 |
Follow Transdermal Patch: new trials by email Literature Review of Transdermal Patch trials Research Report on Transdermal Patch
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Capsaicin in Digital Osteoarthritis Versus Control Capsaicin 179 Mg Cutaneous Patch, Capsaicine low dose 0.04 % - Osteoarthritis Hand, Neuropathic Pain | Phase 4 | Recruiting | University Hospital, Clermont-Ferrand | 120 | 2025-03-07 | 2025-03-13 |
| A COMPARISON OF TRANSDERMAL DICLOFENAC AND ORAL COMBINATION OF PARACETAMOL AND IBUPROFEN IN POSTOPERATIVE PAIN MANAGEMENT FOLLOWING SURGICAL EXTRACTION OF MANDIBULAR THIRD MOLAR- A RANDOMISD CONTROLLED TRIALS. Oral tablet and transdermal patch - Pain, Postoperative | Phase 4 | Unknown | B.P. Koirala Institute of Health Sciences | 108 | 2023-08-10 | 2023-11-24 |
| Preoperative Capsaicin Patch Treatment to Reduce Pain and Pain Sensitivity After Surgery Capsaicin 8% cutaneous patch, Vehicle patch without capsaicin - Postoperative Pain, Hyperalgesia | Phase 4 | Completed | Burkhard Gustorff | 63 | 2023-02-09 | 2026-11-06 |
| A Postmarketing Open-Label Study to Assess Residual Levonorgestrel (LNG) and Ethinyl Estradiol (EE) Content of TWIRLA® (Levonorgestrel and Ethinyl Estradiol) Transdermal System Twirla® (Levonorgestrel/Ethinyl Estradiol) Transdermal System - Residual Drug Amount of EE and LNG | Phase 4 | Completed | Insud Pharma | 28 | 2021-10-25 | 2026-08-27 |
| Evaluation of Mucoadhesive Tacrolimus Patch on Caspase-3 Inducing Apoptosis in Oral Lichen Planus Corticosteroid Topical - Oral Lichen Planus | Phase 4 | Completed | Ain Shams University | 30 | 2019-05-20 | 2021-12-01 |
| The Efficacy and Safety Profile of Capsaicin 8% Patch Versus 5% Lidocaine Patch in Males With Diabetic Neuropathy Lidocaine 5% patch, Capsaicin 8% Patch, Per 10 Square Centimeters - Diabetic Nerve Problems, Diabetic Neuropathy | Phase 4 | Completed | Corporacion Parc Tauli | 290 | 2019-01-10 | 2020-01-30 |
| Localized Neuropathic Pain: Topical Treatment Versus Systemic Treatment Lidocaine patch 5%, Capsaicin 8% Patch, Pregabalin - Neuropathic Pain | Phase 4 | Terminated | University Hospital, Antwerp | 33 | 2018-12-03 | 2021-04-28 |
| Pharmacokinetics of Lidocaine in Healthy Adults Lidocaine 5% patch, Lidocaine hydrochloride, Lidoderm 5% patch - Healthy | Phase 4 | Completed | Nicole K Brogden | 23 | 2018-03-14 | 2021-11-01 |
| Post-Op Lidocaine Patch Lidoderm 5 % Topical Patch, Sham Topical Patch - Pain, Postoperative | Phase 4 | Completed | Oregon Health and Science University | 50 | 2018-03-13 | 2020-03-11 |
| Mobile Health Technology to Enhance Abstinence in Smokers With Schizophrenia Nicotine replacement therapy, Bupropion, cognitive-behavioral smoking cessation counseling - Schizophrenia, Cigarette Smoking | Phase 4 | Completed | Duke University | 35 | 2017-03-27 | 2019-07-10 |
| Adjunctive 5% Lidocaine Patches for Acute Non-radicular Low Back Pain in Emergency Department Patients lidocaine 5% patch, standard therapy, Non-medicated patch - Low Back Pain | Phase 4 | Withdrawn | Cook County Health | 2017-03-10 | 2023-06-29 | |
| Mobile Contingency Management for Concurrent Abstinence From Alcohol and Smoking Nicotine Replacement Therapy, Bupropion, Cognitive Behavioral Treatment - Smoking Cessation, Alcohol Drinking | Phase 4 | Completed | Duke University | 45 | 2016-11-01 | 2021-04-28 |
| Lidoderm Patch (Lidocaine 5%) for Tinnitus Treatment Lidoderm patch (Lidocaine 5% patch), Tegaderm patch. (neutral patch, containing no drug), blood test- serum lidocain levels - Tinnitus | Phase 4 | Unknown | HaEmek Medical Center, Israel | 58 | 2016-04-01 | 2018-02-28 |
| Nicotine Replacement Therapy in the Intensive Care Unit Transdermal nicotine patch, Cutaneous patch, containing no active substances - Delirium, Psychomotor Agitation | Phase 4 | Completed | Gelderse Vallei Hospital | 47 | 2012-06-01 | 2018-10-10 |
| Method of Pre-treatment for Application of QUTENZA Capsaicin 8% Patch QUTENZA, Lidocaine, Tramadol - or Peripheral Nerve Injury (PNI), Peripheral Neuropathic Pain (PNP) Due to Postherpetic Neuralgia (PHN) | Phase 4 | Completed | Astellas Pharma Inc | 122 | 2011-07-06 | 2018-04-23 |
| Evaluation of Treatments to Improve Smoking Cessation Medication Adherence Short Term Combination Nicotine Replacement Therapy (patch + gum), Long Term Combination Nicotine Replacement Therapy (patch + gum), Intensive Maintenance Counseling - Smoking, Smoking Cessation | Phase 4 | Completed | University of Wisconsin, Madison | 544 | 2010-06-01 | 2015-12-11 |
| FS-67 in the Treatment of Pediatric Patients With Ankle Sprain FS-67 Patch, Placebo Patch - Ankle Sprain | Phase 4 | Completed | Hisamitsu Pharmaceutical Co., Inc. | 252 | 2009-12-01 | 2022-10-06 |
| Varenicline Versus Transdermal Nicotine Patch for Smoking Cessation in Patients With Coronary Heart Disease Varenicline, Transdermal Nicotine Patch - Coronary Heart Disease | Phase 4 | Completed | Ottawa Heart Institute Research Corporation | 50 | 2009-04-01 | 2026-05-28 |
| Pharmacokinetic Study of Synera™ in Neonates and Infants lidocaine 70mg and tetracaine 70mg topical patch - Pain | Phase 4 | Suspended | ZARS Pharma Inc. | 11 | 2008-09-01 | 2012-03-23 |
| Kronos Early Estrogen Prevention Study (KEEPS) Conjugated equine estrogens 0.45 mg/day, Transdermal estradiol, 50 mcg/day, Micronized progesterone, 200 mg/day x 12 d/month - Menopause, Arteriosclerosis | Phase 4 | Unknown | Kronos Longevity Research Institute | 728 | 2005-09-01 | 2009-09-14 |
Showing 20 of 22. Sign in to see all of them.
Smoking Cessation (4) · Pain, Postoperative (3) · Coronary Disease (2) · Neuralgia (2) · Smoking (2) · Tobacco Use Disorder (2) · Alcohol Drinking (1) · Ankle Injuries (1) · Arteriosclerosis (1) · Cardiovascular Diseases (1) · Cigarette Smoking (1) · Delirium (1) · Diabetic Neuropathies (1) · Hyperalgesia (1) · Lichen Planus, Oral (1)
Duke University (3) · University of Wisconsin, Madison (2) · Ain Shams University (1) · Astellas Pharma Inc (1) · B.P. Koirala Institute of Health Sciences (1) · Burkhard Gustorff (1) · Cook County Health (1) · Corporacion Parc Tauli (1) · Gelderse Vallei Hospital (1) · HaEmek Medical Center, Israel (1) · Hisamitsu Pharmaceutical Co., Inc. (1) · Insud Pharma (1) · Kronos Longevity Research Institute (1) · Nicole K Brogden (1) · Oregon Health and Science University (1)
United States (12) · Belgium (2) · Austria (1) · Canada (1) · Czechia (1) · Denmark (1) · Egypt (1) · France (1) · Ireland (1) · Israel (1) · Nepal (1) · Netherlands (1) · Norway (1) · Pakistan (1) · Slovakia (1)
Andrew Pipe, MD (1) · Avi Shupak, MD (1) · Ben Jong,de, MD (1) · Burkhard Gustorff, MD (1) · Catherine Leclair, MD (1) · Dennis M Black, PhD (1) · Eric A. Dedert, Ph.D. (1) · Evan Myers, MD, MPH (1) · Frederick Naftolin, MD, PhD (1) · Guy Hans, MD, PhD (1) · Howard Hodis, MD (1) · Jean C Beckham, Ph.D. (1) · Matthew Budoff, MD (1) · Michael C Fiore, MD, MPH, MBA (1) · Michael Mendelsohn, MD (1)
PMID 17888856, PMID 19657788, PMID 19664750, PMID 19996872, PMID 20008701, PMID 22209479, PMID 22587616, PMID 22608375, PMID 23312232, PMID 23322818, PMID 23670850, PMID 23874743, PMID 25069991, PMID 26035291, PMID 27393520, PMID 28364870, PMID 28846767, PMID 29696311, PMID 29881956, PMID 31078511, PMID 31652073, PMID 32015261, PMID 32520900, PMID 32598468, PMID 36395695, PMID 36788511, PMID 37089721, PMID 37142273, PMID 37335995, PMID 39729067, PMID 40050054, PMID 41618732
2015 (1), P50CA143188 (1), P50DA019706 (1)